NEA Partners 16, L.P., 10% Owner at Marker Therapeutics, Inc. (MRKR), bought 554,250 shares at $3.20 ($1.8M) on 2024-12-23, disclosed to the SEC on 2024-12-23.
Open-market purchase of $1.8M MRKR by 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade C.
Nothing distinguishes this filing.
| Filing → |
| GNCA | BUY | 2019-06-25 | $10.0M | — | Filing → |
| GNCA | BUY | 2019-02-19 | $9.4M | — | Filing → |